Skip to content

SWedish Intensive Care Biobank

Hereditary Influence on Risk Factors for Severe Illness in a Swedish Intensive Care Biobank

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07582601
Acronym
SWIC-B
Enrollment
25000
Registered
2026-05-13
Start date
2027-01-01
Completion date
2035-12-30
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any Condition Underlying Critical Illness

Keywords

critical illness, shock, sepsis, heart failure, ards, acute kidney injury, infection, organ failure, intensive care

Brief summary

The goal of this observational study is to understand the genetic and molecular risk factors for developing critical illness in adult intensive care unit (ICU) patients in Sweden. The main questions it aims to answer are: Which genetic variants are associated with increased risk of critical illness from conditions such as infections, sepsis, and organ failure? Can circulating proteins and metabolites mediate the effect of genetic risk factors on the severity of illness? Participants will: Provide blood samples at ICU admission and again 3-6 months after discharge Consent to genetic analysis and data linkage with national health registries Have their ICU treatment and outcomes followed using registry and clinical data This study aims to build a national infrastructure for rapid sample collection and analysis that can also support research in future pandemics.

Interventions

None listed

Sponsors

Uppsala University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults admitted to intensive care in Sweden

Exclusion criteria

* Non adults * Not admitted to intensive care

Design outcomes

Primary

MeasureTime frameDescription
30 day mortality30 daysDeath of any cause within 30 days of ICU admission
ICU admission30 daysICU admission for any specific cause

Contacts

CONTACTMichael Marks-Hultström, MD PhD
michael.hultstrom@mcb.uu.se0186110000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026